Bais, Thomas
Gansevoort, Ron T.
Meijer, Esther
Article History
Accepted: 22 June 2022
First Online: 19 July 2022
Declarations
:
: No financial support was received for the preparation of this article.
: EM received consultancy fees from Otsuka, research funding from Sanofi and the Dutch kidney foundation. RG received consultancy fees and/or research grants from Astra-Zeneca, Bayer, Boehringer-Ingelheim, Galapagos, Ipsen, Mironid, Otsuka and Sanofi. TB has no conflicts of interest to declare. All money was paid to the institution.
: Not applicable.
: Not applicable.
: TB and EM conceived the design of the article. RG critically revised the work. All authors contributed to the literature search and editing of the manuscript. All authors have read and approved the final version of the manuscript.
: Not applicable.